Detalhe da pesquisa
1.
Microevolution of Mycobacterium tuberculosis Subpopulations and Heteroresistance in a Patient Receiving 27 Years of Tuberculosis Treatment in Germany.
Antimicrob Agents Chemother
; 65(7): e0252020, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903103
2.
Discovery of dual-active ethionamide boosters inhibiting the Mycobacterium tuberculosis ESX-1 secretion system.
Cell Chem Biol
; 31(4): 699-711.e6, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181799
3.
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis.
Lancet Microbe
; 4(5): e358-e368, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37003285
4.
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium.
iScience
; 26(4): 106411, 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37091238
5.
Evolutionary Approaches to Combat Antibiotic Resistance: Opportunities and Challenges for Precision Medicine.
Front Immunol
; 11: 1938, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983122
6.
Balancing access to BPaLM regimens and risk of resistance.
Lancet Infect Dis
; 22(10): 1411-1412, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36007529